Saroja Pharma Industries (NSE SME)
August 31, 2023 – September 5, 2023
| Price | ₹84 - ₹84 |
| Premium | ₹ |
|---|---|
| Lot size | 1600 |
| Allotment | Sep 12, 2023 |
| Listing | Sep 13, 2023 |
Saroja Pharma Industries India Limited
305, Kailash Tower, Shiv Shristi Complex,
Goregaon Link Road, Mulund West,
Mumbai (MH) – 400080
Phone: +91 (022) 2081 0011
Email: info@sarojapharma.com
Website: https://www.sarojapharma.com/
Last updated on 05-Sep-2023 17:01:02
| Category | Offered | Applied | Times |
|---|---|---|---|
| NIB | 5,15,200 | 15,36,000 | 2.98 |
| RETAIL | 5,15,200 | 75,95,200 | 14.74 |
| Total | 10,30,400 | 91,31,200 | 8.86 |
| Retail Apps | 4,747 | © IPO Premium | |
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 1600 | 134400 | 0 |
| HNI | 2 | 3200 | 268800 | 0 |
Incorporated in 2019, Saroja Pharma Industries India Limited is engaged in trading, exporting and supplying Specialty Chemicals & API.
The company deals in three types of product categories:
1. Chemical, 2. Pharma Intermediary and 3. Veterinary Pharma API. The company supplies products such as Liquide Bromine, which is used as an agro-intermediate, Ethyl Acetate, which is used as an API solvent, and other pharmaceuticals used for human and veterinary drugs, and some of them are API solvents.
APIs, known as bulk drugs or bulk actives, are the principal ingredients used in making finished dosages in the form of capsules, tablets, liquid or other forms of dosage, with the addition of other APIs or inactive ingredients.
The company exports products mainly in Pakistan, Egypt, Russia, Jordan, Hong Kong, Singapore etc.
Competitive Strength:
- Experienced Promoters and Management Team
- Scalable Business Model
- Wide and diverse range of product offerings
- Diversified business operations and revenue base
Saroja Pharma Industries IPO Details
Saroja Pharma Industries IPO is a Fixed Price Issue. The IPO total issue size is Rs 9.11 Cr. The Saroja Pharma Industries IPO price is ₹84 per share. The IPO will list on NSE SME.
| Issue Size | 1,084,800 shares (aggregating up to ₹9.11 Cr) |
| Fresh Issue | 1,084,800 shares (aggregating up to ₹9.11 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 2,935,686 |
| Share holding post issue | 4,020,486 |
| Market Maker portion | 54,400 shares Swastika Investmart |
Saroja Pharma Industries IPO Reservation
| Other Shares Offered | 50% of the net offer |
| Retail Shares Offered | 50% of the net offer |
Saroja Pharma Industries IPO Lead Manager(s)
Swastika Investmart Ltd
Company Financials
| Period | Mar 2021 | Mar 2022 | Mar 2023 |
| Assets | 822.39 | 1,551.19 | 2,133.99 |
| Revenue | 3,674.67 | 5,595.67 | 5,035.09 |
| Profit | 73.13 | 114.01 | 106.06 |
| Net Worth | 93.59 | 402.60 | 508.66 |
| Reserves | 92.59 | 380.02 | 215.09 |
| Borrowing | 301.77 | 613.88 | 1,018.86 |